the collection combined with the quality of the non-performing debt that the Company bought during the past several years. Revenues from interest and dividend and Profit from loans receivable from
% was the income recognition of the projects completed at the end of 2016. The Company launched 11 projects in 2017 with the combined value of 14,000 million THB. As of 31st December 2017, the backlog of
Consolidated Financial Statements for the third quarter of 2019, reviewed by auditor, to the Stock Exchange of Thailand. The clarification on the Company’s operating results for the third quarter of 2019, are as
Consolidated Financial Statements as of March 31, 2019. The clarification on the Company’s operating results for Q1/2019 are as follows: From the Consolidated Financial Statements for the 1st quarter of 2019
( 105 record(s) found) Name Year Status Type Period As Of Details WE RETAIL PUBLIC COMPANY LIMITED 2021 Audited Company & Consolidated Year 31/12/2021 WE RETAIL PUBLIC COMPANY LIMITED 2013 Audited Company
( 105 record(s) found) Name Year Status Type Period As Of Details WE RETAIL PUBLIC COMPANY LIMITED 2021 Audited Company & Consolidated Year 31/12/2021 WE RETAIL PUBLIC COMPANY LIMITED 2013 Audited Company
Of Details NOVA EMPIRE PUBLIC COMPANY LIMITED 2021 Company Year 31/12/2021 NOVA EMPIRE PUBLIC COMPANY LIMITED 2021 Consolidated Year 31/12/2021 NOVA EMPIRE PUBLIC COMPANY LIMITED 2021 Reviewed
of Directors Meeting regarding the approval of the Company's consolidated financial statements for the Quarter 2 20/21 ended 30 Sep 20, interim dividend payment, and the connected transaction Remark
Details Data not found Finanacial Statements ( 12 record(s) found) Name Year Status Type Period As Of Details NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED 2024 Reviewed Consolidated Q3 30/09/2024
) 3.66 3 .48 3.31 5% 11% Consolidated Revenue1 3,240 2,722 2,942 19% 10% Core EBITDA2,3 369 255 304 45% 21% Combined PET 260 177 192 47% 35% Integrated Oxides and Derivatives 37 13 50 191% (26)% Fibers 72